Canadian Institutes of Health Research – Project Grant: 2021-2026. Role: Co-Principal Investigator with Dr. Rick Ikesaka. Primary thromboprophylaxis with rivaroxaban in patients with malignancy and central venous catheters: TRIM-Line.

Canadian Institutes of Health Research – Project Grant: 2019-2024. Role: Co-Principal Investigator. Co-Principal Investigator: Dr. Aurélien Delluc. Screening for Occult Malignancy in Patients with Unprovoked Venous Thromboembolism: a Randomized Controlled Trial using 18F-Fluorodeoxyglucose Positron Emission Computed Tomography. (SOME-2)

Canadian Institutes of Health Research – COVID-19 Rapid Research Funding Operating Grant. Jul 2020-Jun 2021. Role: Co-Principal Investigator. Co-Principal Investigator: Dr. Deborah Siegal. Venous Thrombosis Virtual Surveillance in COVID (VVIRTUOSO).

Physician’s Services Incorporated Foundation (PSI) – Jul 2020-Jun 2022. Role: Co-Principal Investigator. Co-Principal Investigator: Dr. Joseph Shaw. Global assessment of hemostatic TGA indices following the use of prothrombin complex concentrates for major bleeding or urgent surgery in patients treated with factor Xa inhibitors GAUGE - a prospective observational cohort study.

TOHAMO – The Ottawa Hospital Academic Medical Organization – Innovation Fund: Mar 2019-Mar 2022. Role: Co-Principal Investigator. Co-Principal Investigator: Dr. Rebecca Auer. Creation and implementation of risk-stratified patient decision aid to improve the appropriateness of postoperative extended thromboprophylaxis in patients undergoing abdominal surgery for cancer.

CanVECTOR – Canadian VEnous Thrombosis Clinical Trials ORganisation – Pilot Trial Funding: Oct 2019-Sep 2021 and Canadian Hematology Society – RK Smiley Research Grant. Role: Co-Principal Investigator with Dr. Miriam Kimpton. Thromboprophylaxis with apixaban in polycythemia vera and JAK2-positive essential thrombocythemia patients: A pilot randomized controlled trial assessing feasibility.